FT576 in Subjects With Multiple Myeloma

FT576 in Subjects With Multiple Myeloma
Conditions:   Multiple Myeloma;   Myeloma
Interventions:   Drug: FT576;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Daratumumab
Sponsor:   Fate Therapeutics

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 11, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine